NCT06145217View on ClinicalTrials.gov

An Drug-drug Interaction Study to Evaluate the Effects of Omeprazole 40mg on the Pharmacokinetics of SPRYCEL®

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 22, 2023

Primary Completion Date

August 22, 2023

Study Completion Date

August 29, 2023

Conditions
Drug-drug Interaction Study
Interventions
DRUG

SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole Delayed-Release Capsules USP, 40 mg

To evaluate the drug-drug interaction between SPRYCEL® 100 mg and Omeprazole under fasted conditions in healthy, adult, human subjects.

Trial Locations (1)

500037

QPS Bioserve India Pvt Limited, Hyderabad

All Listed Sponsors
lead

Xspray Pharma AB

INDUSTRY